Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Gordon

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
BMJ Open|December 22, 2023
Social prescribing for children and young people with neurodisability and their families initiated in a hospital setting: a systematic reviewKatie Gordon, Laura Gordon, Anna Purna Basu
The Journal of Family Practice|June 5, 2007
Clinical inquiries. What hormonal contraception is most effective for obese women?Laura Gordon, Netra Thakur, Michel Atlas, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 9, 2010
Xenopus sonic hedgehog guides retinal axons along the optic tractLaura Gordon, Matthew Mansh, Helen Kinsman, et al.
American Journal of Infection Control|June 28, 2014
Evaluating and operationalizing an environmental auditing program: a pilot studyLaura Gordon, Natalie Bruce, Kathryn N Suh, et al.
Development (Cambridge, England)|July 14, 2011
A novel role for MuSK and non-canonical Wnt signaling during segmental neural crest cell migrationSantanu Banerjee, Laura Gordon, Thomas M Donn, et al.
BMC Health Services Research|January 30, 2025
Hospital in-reach family-centred social prescribing pilot for children with neurodisability: mixed methods evaluation with social return on investment analysisLaura Gordon, Megan Hastry, Angela Bate, et al.
Cancer Research|May 14, 2009
NORE1A tumor suppressor candidate modulates p21CIP1 via p53Diego F Calvisi, Howard Donninger, Michele D Vos, et al.
The Journal of Biological Chemistry|April 15, 2011
Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functionsHoward Donninger, Nadia Allen, Adrianna Henson, et al.
American Journal of Perinatology|April 25, 2009
The role of complement in neurodevelopmental impairment following neonatal hypoxic-ischemic encephalopathyHany Aly, Mohamed T Khashaba, Ayman Nada, et al.
Molecular and Cellular Biology|April 7, 2010
The Ras effector RASSF2 controls the PAR-4 tumor suppressorHoward Donninger, Luke Hesson, Michele Vos, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
BMJ Open|December 22, 2023
Social prescribing for children and young people with neurodisability and their families initiated in a hospital setting: a systematic reviewKatie Gordon, Laura Gordon, Anna Purna Basu
The Journal of Family Practice|June 5, 2007
Clinical inquiries. What hormonal contraception is most effective for obese women?Laura Gordon, Netra Thakur, Michel Atlas, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists|October 9, 2010
Xenopus sonic hedgehog guides retinal axons along the optic tractLaura Gordon, Matthew Mansh, Helen Kinsman, et al.
American Journal of Infection Control|June 28, 2014
Evaluating and operationalizing an environmental auditing program: a pilot studyLaura Gordon, Natalie Bruce, Kathryn N Suh, et al.
Development (Cambridge, England)|July 14, 2011
A novel role for MuSK and non-canonical Wnt signaling during segmental neural crest cell migrationSantanu Banerjee, Laura Gordon, Thomas M Donn, et al.
BMC Health Services Research|January 30, 2025
Hospital in-reach family-centred social prescribing pilot for children with neurodisability: mixed methods evaluation with social return on investment analysisLaura Gordon, Megan Hastry, Angela Bate, et al.
Cancer Research|May 14, 2009
NORE1A tumor suppressor candidate modulates p21CIP1 via p53Diego F Calvisi, Howard Donninger, Michele D Vos, et al.
The Journal of Biological Chemistry|April 15, 2011
Salvador protein is a tumor suppressor effector of RASSF1A with hippo pathway-independent functionsHoward Donninger, Nadia Allen, Adrianna Henson, et al.
American Journal of Perinatology|April 25, 2009
The role of complement in neurodevelopmental impairment following neonatal hypoxic-ischemic encephalopathyHany Aly, Mohamed T Khashaba, Ayman Nada, et al.
Molecular and Cellular Biology|April 7, 2010
The Ras effector RASSF2 controls the PAR-4 tumor suppressorHoward Donninger, Luke Hesson, Michele Vos, et al.
Pageof 1